Invention Grant
- Patent Title: Thermostable Cas9 nucleases
-
Application No.: US16469674Application Date: 2016-12-14
-
Publication No.: US11242513B2Publication Date: 2022-02-08
- Inventor: John Van Der Oost , Richard Van Kranenburg , Elleke Fenna Bosma , Ioannis Mougiakos
- Applicant: Wageningen Universiteit , Stichting Voor De Technische Wetenschappen
- Applicant Address: NL Wageningen; NL Utrecht
- Assignee: Wageningen Universiteit,Stichting Voor De Technische Wetenschappen
- Current Assignee: Wageningen Universiteit,Stichting Voor De Technische Wetenschappen
- Current Assignee Address: NL Wageningen; NL Utrecht
- Agency: Riverside Law LLP
- International Application: PCT/EP2016/081077 WO 20161214
- International Announcement: WO2018/108272 WO 20180621
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/90 ; C12N15/11 ; C12N15/113 ; C12N15/63

Abstract:
The present invention relates to the field of genetic engineering and more particularly to nucleic acid editing and genome modification. The present invention provides an isolated Cas protein or polypeptide fragment thereof having an amino acid sequence of SEQ ID NO: 1 or a sequence of at least 77% identity therewith. The Cas protein or polypeptide is capable of binding, cleaving, marking or modifying a double stranded target polynucleotide at a temperature in the range 30° C. and 100° C. inclusive. The invention further provides isolated nucleic acid molecules encoding the Cas9 nucleases, expression vectors and host cells. The invention also provides PAM sequences recognized by the Cas protein or polypeptide, The Cas9 nucleases disclosed herein provide novel tools for genetic engineering at elevated temperatures and are of particular value in the genetic manipulation of thermophilic organisms; particularly microorganisms.
Information query